SAM
Senzar Asset Management Portfolio holdings
AUM
$34.7M
This Quarter Return
-17.68%
1 Year Return
+0.55%
3 Year Return
-0.75%
5 Year Return
–
10 Year Return
–
AUM
$687M
AUM Growth
+$687M
(+18%)
Cap. Flow
+$153M
Cap. Flow
% of AUM
22.29%
Top 10 Holdings %
Top 10 Hldgs %
70.66%
Holding
51
New
13
Increased
20
Reduced
3
Closed
15
Top Buys
| 1 |
Viatris
VTRS
|
$59.8M |
| 2 |
NVRO
NEVRO CORP.
NVRO
|
$55.6M |
| 3 |
AET
Aetna Inc
AET
|
$46.8M |
| 4 |
Amgen
AMGN
|
$28.7M |
| 5 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
$27.5M |
Top Sells
| 1 |
Labcorp
LH
|
$51.3M |
| 2 |
Perrigo
PRGO
|
$36.6M |
| 3 |
Becton Dickinson
BDX
|
$20.8M |
| 4 |
RCPT
RECEPTOS INC COM STK (DE)
RCPT
|
$17.1M |
| 5 |
Medtronic
MDT
|
$16.9M |
Sector Composition
| 1 | Healthcare | 83.9% |
| 2 | Financials | 7.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
NVRO
1
DELISTED
NEVRO CORP.
NVRO
| $102M | 14.88% | 2,205,181 +1,198,702 | +119% | +$55.6M |
|
|
2
Viatris
VTRS
$12.3B
| $69.2M | 10.07% | 1,719,184 +1,485,400 | +635% | +$59.8M |
|
3
Teva Pharmaceuticals
TEVA
$21.1B
| $68.6M | 9.97% | 1,214,494 +336,997 | +38% | +$19M |
|
|
STJ
4
DELISTED
St Jude Medical
STJ
| $54.9M | 7.99% | 870,300 +307,600 | +55% | +$19.4M |
|
|
AET
5
DELISTED
Aetna Inc
AET
| $54M | 7.85% | 493,404 +427,404 | +648% | +$46.8M |
|
|
CNCE
6
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $30.9M | 4.49% | 1,645,673 +88,139 | +6% | +$1.65M |
|
|
7
Amgen
AMGN
$155B
| $28.7M | 4.17% | +207,400 | New | +$28.7M |
|
|
MNK
8
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $27.5M | 4% | +430,200 | New | +$27.5M |
|
9
Biogen
BIIB
$19.4B
| $26.1M | 3.8% | +89,500 | New | +$26.1M |
|
|
TVTY
10
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $23.6M | 3.43% | 2,119,037 +678,534 | +47% | +$7.55M |
|
11
Cigna
CI
$80.3B
| $23.4M | 3.41% | 173,600 +97,300 | +128% | +$13.1M |
|
|
ITCI
12
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $22.3M | 3.24% | 556,224 +394,924 | +245% | +$15.8M |
|
|
ALDR
13
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $18M | 2.62% | +549,900 | New | +$18M |
|
14
Travere Therapeutics
TVTX
$1.56B
| $14.6M | 2.13% | 722,100 +512,600 | +245% | +$10.4M |
|
|
SPNC
15
DELISTED
Spectranetics Corp
SPNC
| $12.1M | 1.75% | 1,022,512 +882,112 | +628% | +$10.4M |
|
|
CORI
16
DELISTED
Corium International, Inc.
CORI
| $11.3M | 1.64% | 1,204,721 +391,636 | +48% | +$3.66M |
|
17
Insmed
INSM
$28.8B
| $10.7M | 1.55% | 575,407 +111,100 | +24% | +$2.06M |
|
18
ANI Pharmaceuticals
ANIP
$2.03B
| $10.7M | 1.55% | +270,040 | New | +$10.7M |
|
|
ELOS
19
DELISTED
Syneron Medical Ltd
ELOS
| $8.52M | 1.24% | 1,191,510 +49,810 | +4% | +$356K |
|
20
Tandem Diabetes Care
TNDM
$845M
| $7.63M | 1.11% | 865,649 +6,100 | +0.7% | +$53.7K |
|
|
XNPT
21
DELISTED
XENOPORT, INC.
XNPT
| $7.46M | 1.09% | 2,150,090 +427,990 | +25% | +$1.49M |
|
|
ACOR
22
DELISTED
Acorda Therapeutics, Inc.
ACOR
| $7.02M | 1.02% | +264,753 | New | +$7.02M |
|
|
DERM
23
DELISTED
Dermira, Inc.
DERM
| $6.89M | 1% | +295,300 | New | +$6.89M |
|
|
FOMX
24
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $6.34M | 0.92% | 864,408 +156,959 | +22% | +$1.15M |
|
25
Orthofix Medical
OFIX
$592M
| $4.56M | 0.66% | 134,984 -225,017 | -63% | -$7.59M |
|